AGENUS INC — Director's Dealing 2023

May 26, 2023

SEC Form 4/A — Form 4/A

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2023-05-01

Reporting Person: AGENUS INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-01	Common Stock	J	5006397	$0.00	Disposed	21326369	Direct

Footnotes

F1: On May 1, 2023, Agenus Inc. ("Agenus") paid its previously announced pro rata stock dividend (the "Dividend") consisting of an aggregate of 5,006,397 shares of common stock of MiNK Therapeutics, Inc. ("MiNK") held by Agenus (the "Dividend Shares") to record holders of Agenus's common stock as of April 17, 2023 (the "Record Date"). Agenus distributed 0.0146 of a share of MiNK's common stock for each share of Agenus's common stock outstanding as of the close of business on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of Agenus who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares.

F2: The Form 4 filed by Agenus on May 3, 2023 inadvertently underreported the number of Dividend Shares distributed to record holders of Agenus's common stock as of the Record Date by 18,316 shares.